Kinase inhibitors
AssigneeInsilico Medicine IP Limited
InventorsAleksandr Aliper, Vladimir Aladinskiy, Aleksandrs Zavoronkovs
Life of this patent
Estimating the term…
Loading patent…
AssigneeInsilico Medicine IP Limited
InventorsAleksandr Aliper, Vladimir Aladinskiy, Aleksandrs Zavoronkovs
Estimating the term…
A TNIK and/or MAP4K4 kinase inhibitor can include: Formula A, derivative, prodrug, salt, stereoisomer, tautomer polymorph, or solvate thereof, or having chirality at any chiral center, wherein: ring 1 is an aromatic ring with or without hetero atoms; ring 2 is a hetero aromatic ring; ring 3 includes at least one hetero aromatic ring and optionally at least one cycloaliphatic ring fused with the at least one hetero aromatic ring; ring 4 is an aromatic ring with or without hetero atoms; Y is a bond or a linker; Y1 is a linker; each n is independently 0, 1, or 2; each o is independently 0, 1, 2, 3, 4, or 5; each R1, R6, R11, and R12 is independently a substituent; and RA is a ring structure, straight aliphatics, or branched aliphatics, which can be substituted or unsubstituted, any with or without hetero atoms.
A compound, comprising:
(canceled)
(canceled)
A compound of a structure of Formula A1 a salt thereof, or a stereoisomer thereof,
13-28. (canceled)
A compound of a structure of Formula A2, a salt thereof, or a stereoisomer thereof,
Dependencies are inferred from the claim text.